ACRS vs MDT · rev $3.6M vs P/E 21, rev $36.36B
Aclaris Therapeutics Inc (ACRS) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ACRS currently screens at market cap $615.9M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ACRS and MDT stock pages for the full models.
Not investment advice.